BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27659181)

  • 1. The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.
    Leal AS; Sporn MB; Pioli PA; Liby KT
    Carcinogenesis; 2016 Dec; 37(12):1170-1179. PubMed ID: 27659181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
    Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R
    Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
    Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
    Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of thymic tumor in [LSL:Kras
    Liot S; El Kholti N; Balas J; Genestier L; Verrier B; Valcourt U; Lambert E
    Sci Rep; 2021 Jul; 11(1):15075. PubMed ID: 34302028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
    Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY
    Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
    Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
    Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
    Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
    J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice.
    Kaur K; Chang HH; Topchyan P; Cook JM; Barkhordarian A; Eibl G; Jewett A
    Front Immunol; 2018; 9():1229. PubMed ID: 29977235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
    Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S
    Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice.
    Hoffman MT; Kemp SB; Salas-Escabillas DJ; Zhang Y; Steele NG; The S; Long D; Benitz S; Yan W; Margolskee RF; Bednar F; Pasca di Magliano M; Wen HJ; Crawford HC
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):349-369. PubMed ID: 32882403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rho/MRTF pathway inhibitor CCG-222740 reduces stellate cell activation and modulates immune cell populations in Kras
    Leal AS; Misek SA; Lisabeth EM; Neubig RR; Liby KT
    Sci Rep; 2019 May; 9(1):7072. PubMed ID: 31068602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge.
    Auletta JJ; Alabran JL; Kim BG; Meyer CJ; Letterio JJ
    J Interferon Cytokine Res; 2010 Jul; 30(7):497-508. PubMed ID: 20626291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Models of Pancreatitis Leading to the Development of Pancreatic Cancer.
    Leal AS; Liby KT
    Curr Protoc Pharmacol; 2018 Dec; 83(1):e48. PubMed ID: 30325112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway.
    Ahmed H; Amin U; Sun X; Pitts DR; Li Y; Zhu H; Jia Z
    Exp Biol Med (Maywood); 2022 Apr; 247(8):683-690. PubMed ID: 35034476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pdx1 expression in hematopoietic cells activates
    Walcheck MT; Nukaya M; Ranheim EA; Matkowskyj KA; Ronnekleiv-Kelly S
    Leuk Lymphoma; 2023 Jun; 64(6):1112-1122. PubMed ID: 37081806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.